| P50 | author | Michael Nonnemacher | Q55273616 |
| | Satinder Dahiya | Q59296143 |
| P2093 | author name string | Brian Wigdahl | |
| P2860 | cites work | Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells | Q36399936 |
| | Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication | Q36401561 |
| | Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways | Q36499676 |
| | CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. | Q36556421 |
| | Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. | Q36699534 |
| | HIV-1 matrix protein: a mysterious regulator of the viral life cycle | Q36702218 |
| | Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. | Q36710904 |
| | Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies | Q36813044 |
| | Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates | Q36882975 |
| | Regulation of HIV-1 latency by T-cell activation. | Q36887625 |
| | HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. | Q37062107 |
| | Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection | Q37066263 |
| | Suppression of HIV-1 replication by microRNA effectors | Q37133970 |
| | APOBEC proteins and intrinsic resistance to HIV-1 infection | Q37140468 |
| | Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes | Q37145340 |
| | Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death | Q37183208 |
| | Cellular reservoirs of HIV-1 and their role in viral persistence | Q37196089 |
| | HIV interactions with monocytes and dendritic cells: viral latency and reservoirs | Q37229398 |
| | Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages | Q37273948 |
| | HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells | Q36370102 |
| | CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection | Q36371384 |
| | HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression | Q21245193 |
| | Global landscape of HIV-human protein complexes | Q24300336 |
| | Identification of host proteins required for HIV infection through a functional genomic screen | Q24306298 |
| | The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription | Q24307870 |
| | The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling | Q24322710 |
| | Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients | Q24538755 |
| | Induction of G2 arrest and binding to cyclophilin A are independent phenotypes of human immunodeficiency virus type 1 Vpr | Q24543218 |
| | Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism | Q24594703 |
| | Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid | Q24596282 |
| | CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells | Q24633405 |
| | Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter | Q24634457 |
| | Crystal structure of HIV-1 Tat complexed with human P-TEFb | Q24634569 |
| | Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production | Q24682936 |
| | HIV-1 nef suppression by virally encoded microRNA | Q24803620 |
| | Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? | Q24816505 |
| | Changes in microRNA expression profiles in HIV-1-transfected human cells | Q25257532 |
| | Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication | Q27497968 |
| | DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation | Q28139929 |
| | Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans | Q28140638 |
| | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA | Q28203201 |
| | A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication | Q28245811 |
| | Controlling the elongation phase of transcription with P-TEFb | Q28255518 |
| | Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1 | Q28261598 |
| | Repression of MHC class I gene promoter activity by two-exon Tat of HIV | Q28269206 |
| | Role of viral regulatory and accessory proteins in HIV-1 replication | Q28280802 |
| | Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans | Q28345408 |
| | The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product | Q28368083 |
| | Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs | Q42118138 |
| | Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity | Q42157622 |
| | Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication | Q42282677 |
| | Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid | Q42485695 |
| | Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. | Q42755157 |
| | Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines | Q42944655 |
| | HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity | Q43716009 |
| | Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. | Q43792135 |
| | Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons. | Q44010197 |
| | Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction | Q44483444 |
| | Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate | Q44535607 |
| | HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection | Q45345418 |
| | Early viral brain invasion in iatrogenic human immunodeficiency virus infection | Q45868985 |
| | Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement | Q46142126 |
| | Transient-mediated fate determination in a transcriptional circuit of HIV. | Q50642600 |
| | Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing | Q50768291 |
| | Targets for human encoded microRNAs in HIV genes | Q57076044 |
| | The HIV-1 Nef protein has a dual role in T cell receptor signaling in infected CD4+ T lymphocytes | Q57565041 |
| | Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1 | Q58377824 |
| | Effects of integration and replication on transcription of the HIV-1 long terminal repeat | Q72571845 |
| | Macrophages as a source of HIV during opportunistic infections | Q73427586 |
| | CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells | Q74587983 |
| | HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1 | Q80089462 |
| | Mechanisms for HIV Tat upregulation of IL-10 and other cytokine expression: kinase signaling and PKR-mediated immune response | Q81770906 |
| | HIV-Nef and AIDS pathogenesis: are we barking up the wrong tree? | Q84602577 |
| | HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination | Q28474374 |
| | Epigenetic regulation of HIV-1 latency by cytosine methylation | Q28475636 |
| | Ribo-gnome: the big world of small RNAs | Q29615681 |
| | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication | Q29616375 |
| | HIV-1 integration in the human genome favors active genes and local hotspots | Q29618457 |
| | HIV-1 accessory proteins--ensuring viral survival in a hostile environment | Q29619538 |
| | Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 |
| | HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction | Q30159721 |
| | Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses | Q30391530 |
| | "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence | Q30488246 |
| | Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery | Q31577177 |
| | OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions | Q31814830 |
| | Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology | Q32068509 |
| | Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity | Q33220546 |
| | HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT | Q33265220 |
| | NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site | Q33266806 |
| | The Ebola virus VP35 protein is a suppressor of RNA silencing | Q33288729 |
| | HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR | Q33292464 |
| | Interfering RNA and HIV: reciprocal interferences | Q33372109 |
| | miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1 | Q33400321 |
| | The SET complex acts as a barrier to autointegration of HIV-1 | Q33415459 |
| | Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation | Q33425135 |
| | Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection | Q33476165 |
| | CpG methylation controls reactivation of HIV from latency | Q33495565 |
| | Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation | Q33508788 |
| | Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage | Q33587139 |
| | Regulation of SIV mac 239 basal long terminal repeat activity and viral replication in macrophages: functional roles of two CCAAT/enhancer-binding protein beta sites in activation and interferon beta-mediated suppression | Q33593821 |
| | Association of Tat with Promoters of PTEN and PP2A Subunits Is Key to Transcriptional Activation of Apoptotic Pathways in HIV-Infected CD4+ T Cells | Q33700607 |
| | The macrophage in HIV-1 infection: from activation to deactivation? | Q33810779 |
| | Vpr-host interactions during HIV-1 viral life cycle | Q33828332 |
| | A re-examination of global suppression of RNA interference by HIV-1. | Q33840754 |
| | Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells | Q33851786 |
| | Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage | Q33864438 |
| | Combinatorial latency reactivation for HIV-1 subtypes and variants | Q33877492 |
| | Protein phosphatase-1 activates CDK9 by dephosphorylating Ser175. | Q33886004 |
| | Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon | Q33889326 |
| | Cellular microRNA and P bodies modulate host-HIV-1 interactions | Q37391014 |
| | Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid | Q37406083 |
| | Chromatin dynamics associated with HIV-1 Tat-activated transcription | Q37589012 |
| | Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis | Q37596477 |
| | The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors | Q37613764 |
| | Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies | Q37644561 |
| | Curing HIV: Pharmacologic approaches to target HIV-1 latency | Q37645582 |
| | Macrophage signaling in HIV-1 infection | Q37728093 |
| | HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS. | Q37785252 |
| | Analysis of the roles of HIV-derived microRNAs | Q37816443 |
| | Epigenetic regulation of HIV latency | Q37829626 |
| | A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system | Q37829628 |
| | Macrophages and HIV-1. | Q37898469 |
| | The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models | Q37900419 |
| | Mechanisms of RNA interference in the HIV-1-host cell interplay. | Q37907829 |
| | Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system | Q37974980 |
| | High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. | Q38341208 |
| | Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2. | Q38356666 |
| | HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. | Q38356699 |
| | Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. | Q39270892 |
| | Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR | Q39595632 |
| | Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction | Q39712159 |
| | The NS3 protein of rice hoja blanca virus complements the RNAi suppressor function of HIV-1 Tat. | Q39883609 |
| | Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression | Q39885717 |
| | SJ23B, a jatrophane diterpene activates classical PKCs and displays strong activity against HIV in vitro | Q39902859 |
| | Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency | Q39933477 |
| | Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. | Q40009476 |
| | TAT-Hsp40 inhibits oxidative stress-mediated cytotoxicity via the inhibition of Hsp70 ubiquitination. | Q40015511 |
| | Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study | Q40130110 |
| | Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation | Q40132386 |
| | Suppression of microRNA-silencing pathway by HIV-1 during virus replication | Q40166750 |
| | Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes | Q40280905 |
| | Nef-mediated lipid raft exclusion of UbcH7 inhibits Cbl activity in T cells to positively regulate signaling | Q40339753 |
| | A role for LEDGF/p75 in targeting HIV DNA integration | Q40346940 |
| | Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages | Q40358843 |
| | Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells | Q40435387 |
| | Regulation of human immunodeficiency virus 1 transcription by nef microRNA. | Q40456215 |
| | HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB. | Q40478718 |
| | Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression | Q40507650 |
| | A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression. | Q40557365 |
| | Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts | Q40572781 |
| | HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. | Q40690555 |
| | Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. | Q41868116 |
| | Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence | Q41929326 |
| | Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes | Q41994305 |
| | Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency | Q42100247 |
| | Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes | Q33895074 |
| | Emergence of a complex relationship between HIV-1 and the microRNA pathway | Q34025960 |
| | Role of chromatin in HIV-1 transcriptional regulation | Q34033128 |
| | Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns | Q34206910 |
| | Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR. | Q34387337 |
| | Step out of the groove: epigenetic gene control systems and engineered transcription factors | Q34531990 |
| | Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1 transcription | Q34537015 |
| | The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit | Q34544409 |
| | Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy | Q34588169 |
| | Hematopoietic stem/precursor cells as HIV reservoirs. | Q34610023 |
| | Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activation | Q34647406 |
| | Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment | Q34671618 |
| | Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes | Q34695803 |
| | Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients | Q34725556 |
| | Histone deacetylase inhibitors and HIV latency | Q34816844 |
| | HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention | Q34957142 |
| | Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders | Q35022812 |
| | HIV Tat, its TARgets and the control of viral gene expression | Q35088029 |
| | Inhibition of PP2A by LIS1 increases HIV-1 gene expression | Q35098682 |
| | Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. | Q35114694 |
| | Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells | Q35213780 |
| | MicroRNAs and human retroviruses | Q35226238 |
| | Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. | Q35266342 |
| | Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity | Q35761152 |
| | Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients | Q35799435 |
| | Interplay between HIV-1 infection and host microRNAs | Q35823730 |
| | Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes. | Q35826285 |
| | Role of β-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. | Q35826464 |
| | Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. | Q35832979 |
| | The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor | Q35834594 |
| | Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. | Q35866513 |
| | Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection | Q36225040 |
| | siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code | Q36325641 |
| P433 | issue | Pt 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1151-1172 | |
| P577 | publication date | 2012-03-14 | |
| P1433 | published in | Journal of General Virology | Q6295245 |
| P1476 | title | Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development | |
| P478 | volume | 93 | |